- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07821125
Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy
Effects of Urotherapy Education Provided to Families of Children With Duchenne Muscular Dystrophy on Knowledge, Lifestyle Changes, and Training Satisfaction
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder that may also be accompanied by lower urinary tract symptoms. Urotherapy is a conservative, non-pharmacological approach that includes education on bladder and bowel function, appropriate voiding and defecation habits, lifestyle modifications, and strategies for managing lower urinary tract symptoms.
This prospective interventional study will evaluate the effects of an online urotherapy education program provided to families of children with DMD. The education will be delivered remotely in a single session of approximately three hours. Participants will be assessed before the education, immediately after the education, and two weeks later and 2 months after. The study will examine changes in parents' knowledge and awareness of urotherapy-related behaviors and lifestyle practices, as well as their satisfaction with the education provided.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Demet Öztürk, Phd
- Numero di telefono: 905068394288
- Email: demett.ozturkk@gmail.com
Luoghi di studio
-
-
Ankara
-
Ankara, Ankara, Turchia (Türkiye), 06370
- Lokman Hekim University, Ankara, Ankara
-
Contatto:
- Demet Öztürk, Phd
- Numero di telefono: 05068394288
- Email: demett.ozturkk@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Being a parent or caregiver of a child diagnosed with Duchenne muscular dystrophy.
- Volunteering to participate in the study.
- Providing informed consent.
- Being able to participate in the online urotherapy education and complete the study assessments.
Exclusion Criteria:
- Not completing the urotherapy education session.
- Not completing the required study assessments.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Altro: Urotherapy Education Group
Participants in this arm will receive a single online urotherapy education session lasting approximately three hours.
The education will include information on lower urinary tract anatomy and function, bladder and bowel symptoms, appropriate voiding and defecation habits and postures, lifestyle modifications, fluid intake, and strategies for managing lower urinary tract symptoms.
Knowledge and awareness will be assessed before the education, immediately after the education, and two weeks later and eight weeks later, and satisfaction with the education will be evaluated after the session.
|
Participants will receive a single online urotherapy education session lasting approximately three hours.
The education will include information about lower urinary tract anatomy and function, lower urinary tract symptoms, bladder and bowel habits, appropriate voiding and defecation postures, scheduled voiding and defecation, fluid intake, lifestyle modifications, pelvic floor muscle awareness, and general strategies for managing lower urinary tract symptoms.
Educational materials may include visual materials, videos, and other supporting resources.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Urotherapy Knowledge Level
Lasso di tempo: Baseline, two weeks after, 8 weeks after
|
Parents' knowledge of urotherapy will be assessed using a 10-item knowledge test developed by the researchers based on the educational content.
The test consists of five true/false and five multiple-choice questions.
Each correct answer is worth 10 points, resulting in a total score ranging from 0 to 100.
Higher scores indicate a higher level of knowledge about urotherapy.
|
Baseline, two weeks after, 8 weeks after
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Urotherapy-Related Lifestyle Behaviors
Lasso di tempo: After 2 weeks and 8 weeks
|
Urotherapy-related lifestyle behaviors will be assessed using awareness questions developed by the researchers.
The questions evaluate voiding frequency, defecation frequency, daily water intake, consumption of tea, coffee, and carbonated beverages, appropriate toileting posture, and implementation of lifestyle recommendations introduced during the urotherapy education.
Changes in these behaviors after the education will be evaluated.
|
After 2 weeks and 8 weeks
|
|
Satisfaction With Urotherapy Education
Lasso di tempo: Baseline
|
Satisfaction with the urotherapy education will be assessed using an 8-item satisfaction questionnaire developed by the researchers.
Each item is rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
The total score ranges from 8 to 40, with higher scores indicating greater satisfaction with the education.
|
Baseline
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie muscoloscheletriche
- Malattie del sistema nervoso
- Malattie muscolari
- Malattie neuromuscolari
- Malattie genetiche, congenite
- Manifestazioni urologiche
- Malattie genetiche, legate all'X
- Disturbi muscolari, atrofico
- Distrofie muscolari
- Malattie e anomalie congenite, ereditarie e neonatali
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Distrofia muscolare, Duchenne
- Sintomi del tratto urinario inferiore
Altri numeri di identificazione dello studio
- 2022/12
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .